✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
591daili 济南圣和化工
首页 › 产品目录 › Enasidenib

Enasidenib

CAS 1446502-11-9C19H17F6N7OMW 473.4

Enasidenib,CAS 登记号 1446502-11-9,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于Organic Chemicals。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号1446502-11-9
分子式C19H17F6N7O
分子量473.4
LogP3.5
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域Organic Chemicals
类别Organic Chemicals

用途与场景

Organic Chemicals

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 Enasidenib 的 CAS 号?

本页已列出 Enasidenib 的 CAS 号:1446502-11-9,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

Enasidenib 一般用在什么产品里?

主要涉及Organic Chemicals。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Enasidenib · CAS 1446502-11-9 · C19H17F6N7O. UNII 3T1SS4E7AG.

Identification

CAS Registry Number1446502-11-9
PubChem CID89683805
Molecular formulaC19H17F6N7O
IUPAC name2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol
UNII (FDA)3T1SS4E7AG

Computed Descriptors

Molecular Weight473.4
XLogP33.5
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count14
Rotatable Bond Count6
Exact Mass473.13987716
Monoisotopic Mass473.13987716
Topological Polar Surface Area109
Heavy Atom Count33
Formal Charge0

GHS Hazard Classification

Reported hazard statementsH360 (50%), H373 (100%), H413 (50%)

H360 (50%): May damage fertility or the unborn child [Danger Reproductive toxicity]

H361f (50%): Suspected of damaging fertility [Warning Reproductive toxicity]

Documented Uses

  • Enasidenib is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test.
  • Enasidenib is an orally available small molecule inhibitor of mutant isocitrate dehydrogenase-2 that is used in the therapy of selected cases of acute myelogenous leukemia (AML). Enasidenib is associated with a moderate rate of serum aminotransferase elevations during therapy and is suspected to cause rare instances of clinically apparent acute liver injury.
  • Breast Feeding; Lactation; Antineoplastic Agents; Enzyme Inhibitors; Isocitrate Dehydrogenase Inhibitors
  • Exercise caution with grapefruit products. Grapefruit inhibits CYP3A4 metabolism, which may increase the serum concentration of enasidenib; however, CYP3A4 is one of many enzymes involved in enasidenib metabolism.
  • Exercise caution with St. John's Wort. This herb induces CYP3A4 metabolism, which may reduce the serum concentration of enasidenib; however, CYP3A4 is one of many enzymes involved in enasidenib metabolism.
  • Take at the same time every day.

Synonyms

Enasidenib; 1446502-11-9; CC-90007 Free Base; enasidenibum; 3T1SS4E7AG; CHEBI:145374; DTXSID801027942; RefChem:58279; L01XX59; DTXCID401513509; 107-597-8; AG-221; IDHIFA; AG-221 (Enasidenib); Enasidenib [INN]; AG 221

Frequently Asked Questions

What are the CAS number and molecular formula of Enasidenib?

CAS 1446502-11-9; molecular formula C19H17F6N7O; molecular weight — g/mol.

What other names is Enasidenib known by?

Enasidenib, 1446502-11-9, CC-90007 Free Base, enasidenibum, 3T1SS4E7AG, CHEBI:145374.

Is Enasidenib classified as hazardous?

Hazard statements reported: H360, H373, H413.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 Enasidenib 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1